154 related articles for article (PubMed ID: 29802561)
1. Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages.
de Figueiredo Junior AG; Serafim PVP; de Melo AA; Felipe AV; Lo Turco EG; da Silva IDCG; Forones NM
Asian Pac J Cancer Prev; 2018 May; 19(5):1287-1293. PubMed ID: 29802561
[TBL] [Abstract][Full Text] [Related]
2. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
[TBL] [Abstract][Full Text] [Related]
3. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
[TBL] [Abstract][Full Text] [Related]
4. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
5. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
[TBL] [Abstract][Full Text] [Related]
6. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
Lee JH; Kim KH; Park JW; Chang HJ; Kim BC; Kim SY; Kim KG; Lee ES; Kim DY; Oh JH; Yoo BC; Kim IH
Int J Cancer; 2014 Apr; 134(8):1844-53. PubMed ID: 24096867
[TBL] [Abstract][Full Text] [Related]
7. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
[TBL] [Abstract][Full Text] [Related]
8. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
Liu C; Pan C; Shen J; Wang H; Yong L
Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
10. Metabonomics identifies serum metabolite markers of colorectal cancer.
Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
[TBL] [Abstract][Full Text] [Related]
11. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
12. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
[TBL] [Abstract][Full Text] [Related]
13. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
14. Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.
Lee JH; Kim YH; Kim KH; Cho JY; Woo SM; Yoo BC; Kim SC
Cancer Res Treat; 2018 Jul; 50(3):883-893. PubMed ID: 28934848
[TBL] [Abstract][Full Text] [Related]
15. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
[TBL] [Abstract][Full Text] [Related]
16. Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.
Liao CC; Mehta A; Ward NJ; Marsh S; Arulampalam T; Norton JD
World J Surg Oncol; 2010 Apr; 8():33. PubMed ID: 20420661
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
[TBL] [Abstract][Full Text] [Related]
20. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]